MIP-1072

Overview

MIP-1072 is a competitive prostate-specific membrane antigen ( PSMA ) inhibitor with a K i value of 4.6 nM. MIP-1072 specifically binds to PSMA and is internalized into PSMA -expressing prostate cancer cells. MIP-1072 accumulates in PSMA -expressing prostate cancer xenografts. MIP-1072 specifically blocks the uptake of 68 Ga-NOTA-GUL by PSMA -positive prostate cancer xenografts. When radiolabeled with 123 I, MIP-1072 functions as a SPECT/CT molecular imaging agent. MIP-1072 can be used in prostate cancer-related research.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Antibody-Drug Conjugate/ADC Related | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > PSMA | Products > Signaling Pathways > Radionuclide-Drug Conjugates (RDCs)

Product Information

• Catalog No.: HY-129615
• CAS No.: 949575-20-6
• Molecular Formula: C19H26IN3O7
• Molecular Weight: 535.33
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source